Newark, New Castle, USA, April 11, 2023 (GLOBE NEWSWIRE) — As per the report by Growth Plus Reports, the global pulse electromagnetic field therapy devices market was valued at US$ 422.20 million in 2022 and is expected to reach US$ 851.04 million, registering a revenue CAGR of 8.1% by 2031.
The global pulse electromagnetic field therapy devices market was valued and expected to rise with a significant revenue share during the forecast period. Devices for pulse electromagnetic field (PEMF) therapy are medical tools that stimulate the body’s cells and tissues using electromagnetic fields. These tools support the body’s healing mechanisms while enhancing circulation and reducing inflammation.
Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/pulse-electromagnetic-field-therapy-devices-market/8560
Pulse Electromagnetic Field Therapy Devices Market Scope
|Market size value in 2022||US$ 422.20 million|
|Revenue forecast in 2031||US$ 851.04 million|
|Growth Rate||CAGR of 8.1% from 2023 to 2031|
|Base year for estimation||2022|
|Segments covered||Device, Application, End User, and Region.|
|Regional scope||North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa|
Recent Development in Pulse Electromagnetic Field Therapy Devices Market:
- In March 2023, to commercialize its flagship product, SofPulse, in Taiwan, Endonovo Therapeutics, Inc., a medical device business renowned for its efficient pain management solutions, said it is close to receiving approval for a Taiwan FDA (TFDA) License for Medical Devices.
- Aging populations globally and more knowledge of pulse electromagnetic field (PEMF) therapy devices
- The prevalence of diseases like arthritis, osteoporosis, and fibromyalgia is increasing in demand.
- Growing awareness of PCC among healthcare providers and patients is increasing the market demand.
Market Drivers and Restraints: